<DOC>
	<DOCNO>NCT00717093</DOCNO>
	<brief_summary>The primary goal study compare efficacy varenicline placebo cessation use smokeless tobacco .</brief_summary>
	<brief_title>Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Lobeline</mesh_term>
	<criteria>Male female daily smokeless tobacco user age 18 year old , motivate stop use tobacco product . Subjects must daily user nicotine contain smokeless tobacco use smokeless tobacco least 8 occasion per day average week . Have use smokeless tobacco least 1 year prior screening period abstinence &gt; 3 month past year . Subjects use nicotine containing product ( include smoke tobacco ) smokeless tobacco 3 month prior screen . Subjects exhale Carbon Monoxide ( CO ) &gt; 10 ppm baseline . Subjects use varenicline , bupropion , NRT within 3 month screen . Subjects currently within past 12 month require treatment depression current prior history panic disorder , psychosis , bipolar disorder serious mental illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>